At the conclusion of most lead hazard control interventions in federally assisted housing built before 1978, a certified clearance examiner must verify that the lead hazard control work was completed as specified and that the area is safe for residents, a process referred to as clearance. This study explores the experience of 14 grantees participating in the Evaluation of the HUD Lead-Based Paint Hazard Control Grant Program in passing clearance. The study also considers how preintervention lead levels (interior dust and paint), building condition/characteristics, and the scope of work influenced initial clearance dust lead loadings and clearance rates. At the initial clearance inspection, 80% of the 2682 dwellings achieved grantee-specific clearance standards on windowsills, window troughs (500 microg/ft2 and 800 microg/ft2, respectively), and floors (80, 100, or 200 microg/ft2 depending on state/local regulations at the dates of clearance in the mid-1990s), with individual grantee success rates ranging from 63 to 100%. Dwellings that failed initial clearance required an average of 1.13 retests to clear. The high level of success at clearance demonstrates that following methods for work site containment, lead hazard control, and cleaning similar to those recommended in the HUD Guidelines for the Evaluation and Control of Lead-Based Paint in Housing is effective. The most common lead hazard control intervention was window abatement accompanied by the repair or abatement of all other deteriorated lead-based paint (56% of dwellings). An additional 5% of dwellings were fully abated, 29% had lower intensity interventions. Interventions including window replacement are recommended to reduce dust lead loading on windowsills and troughs at clearance, but lower level interventions such as full paint stabilization are just as good at reducing floor dust lead loadings. Whatever lead hazard control activities are selected, the condition of the surfaces of interest should be in good condition at clearance.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1080/15459620490520792 | DOI Listing |
Jpn J Ophthalmol
January 2025
Department of Ophthalmology, Graduate of Medicine, Faculty of Medicine, The University of Tokyo, Tokyo, Japan.
Purpose: To assess the efficacy and safety of PreserFlo MicroShunt (PMS) combined with mitomycin C in patients with medically treated primary open-angle glaucoma (POAG).
Study Design: A retrospective observational study.
Methods: The study examined 83 eyes from 83 patients with medically treated glaucoma surgery naive POAG.
Curr Cardiol Rep
January 2025
Division of Cardiology, Department of Internal Medicine II, Medical University of Vienna, Waehringer Guertel 18-20, 1090, Vienna, Austria.
Purpose Of Review: Metabolic dysfunction-associated steatotic liver disease (MASLD) is the most common chronic liver disease, characterized by hepatic steatosis with at least one cardiometabolic risk factor. Patients with MASLD are at increased risk for the occurrence of cardiovascular events. Within this review article, we aimed to provide an update on the pathophysiology of MASLD, its interplay with cardiovascular disease, and current treatment strategies.
View Article and Find Full Text PDFLangenbecks Arch Surg
January 2025
Department of Trauma Surgery, University Hospital Zurich, Rämistrasse 100, CH - 8091, Zurich, Switzerland.
Introduction: Blunt traumatic aortic injury (TAI) is a critical condition and a leading cause of mortality in trauma patients, often resulting from high-speed accidents. Thoracic endovascular aortic repair (TEVAR) has developed into the preferred therapeutic approach due to its minimally invasive nature and promising outcomes. This study evaluates the safety and efficacy of TEVAR for managing TAI over a 10-year period at a Level-1 trauma center.
View Article and Find Full Text PDFAppl Microbiol Biotechnol
January 2025
National Engineering Research Center of Green Feeds and Healthy Livestock Industry, Hangzhou, 310058, Zhejiang, China.
The widespread use of antibiotics has led to the emergence of multidrug-resistant bacteria, which pose significant threats to animal health and food safety. Host defense peptides (HDPs) have emerged as promising alternatives because of their unique antimicrobial properties and minimal resistance induction. However, the high costs associated with HDP production and incorporation into animal management practices hinder their widespread application.
View Article and Find Full Text PDFInt J Cancer
January 2025
Department of Radiation Oncology, Guangxi Medical University Cancer Hospital, Nanning, Guangxi, China.
The effectiveness and safety of combining anlotinib with gemcitabine and cisplatin in the first-line treatment of recurrent/metastatic nasopharyngeal carcinoma (R/M NPC) have not been definitively established. This research seeks to investigate the potential benefits and risks of utilizing this combination therapy in the first-line management of R/M NPC. The research involved 22 individuals diagnosed with R/M NPC and who had not undergone any previous treatment.
View Article and Find Full Text PDFEnter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!